Accelerate Diagnostics Inc.
13F holders, Q2 2024 (June 30)1holders
0new positions
0sold out
$1.17avg. 13F price*
At the end of Q2 2024, 1 institutions reported holding Accelerate Diagnostics Inc. in their 13F filings, unchanged from Q1 2024. 0 opened new positions and 0 sold out. The largest holder was Birchview Capital, LP ($381K).
- Company
- Accelerate Diagnostics Inc.
- CUSIP
- 00430H102
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| Birchview Capital, LP | 0.35% | No change | 325,239 | $381K |
"% of holder's portfolio" is ACCELERATE DIAGNOSTICS INC's weight in each manager's 13F, not the share of Accelerate Diagnostics Inc. the manager owns.